首页> Journal of nuclear medicine : official publication, Society of Nuclear Medicine> Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer.

Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Chloé S,Denis

第一单位： Medical Oncology Department, University Hospital of Liege, Liege, Belgium; chloe.denis@chuliege.be.

作者： Chloé S,Denis ^[1] ; François,Cousin ^[2] ; Bram,De Laere ^[3] ; Jan,Vanwelkenhuyzen ^[4] ; Roland,Hustinx ^[5] ; Brieuc R,Sautois ^[6] ; Nadia,Withofs ^[5]

作者单位： Medical Oncology Department, University Hospital of Liege, Liege, Belgium; chloe.denis@chuliege.be. ^[1] Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, University Hospital of Liege, Liege, Belgium. ^[2] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.;Department of Human Structure and Repair, Ghent University, Ghent, Belgium; and. ^[3] Department of Human Structure and Repair, Ghent University, Ghent, Belgium; and. ^[4] Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, University Hospital of Liege, Liege, Belgium.;GIGA-CRC In Vivo Imaging, University of Liege, Liege, Belgium. ^[5] Medical Oncology Department, University Hospital of Liege, Liege, Belgium. ^[6]

关键词 ARPI PET/CT PSMA interlesional prostate cancer